March 03, 2015 8:01 AM ET


Company Overview of vasopharm GmbH

Company Overview

vasopharm GmbH, a pharmaceutical company, engages in the discovery and development of therapeutics for the treatment of cerebro and cardiovascular diseases, and their consequences. Its therapeutic pipeline VAS203, an allosteric nitric oxide synthase inhibitor interacting with the BH4 binding site of the enzyme; and VAS2870, a NAD(P)H oxidase (NOX) modulator for the treatment of peripheral arterial occlusive diseases. The company was founded in 1998 and is based in Wuerzburg, Germany.

Friedrich-Bergius-Ring 15

Wuerzburg,  97076


Founded in 1998


49 931 35 90 99 0


49 931 35 90 99 12

Key Executives for vasopharm GmbH

Co-Founder and Chief Executive Officer
Head of Chemistry & Manufacturing
Chief Technology Officer
Compensation as of Fiscal Year 2014.

vasopharm GmbH Key Developments

vasopharm GmbH Presents at BIO-Europe 2014, Nov-03-2014 05:15 PM

vasopharm GmbH Presents at BIO-Europe 2014, Nov-03-2014 05:15 PM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Christian Wandersee, CEO.

vasopharm GmbH Presents at BioEquity Europe 2013, May-23-2013 03:30 PM

vasopharm GmbH Presents at BioEquity Europe 2013, May-23-2013 03:30 PM. Venue: Sheraton Stockholm, Stockholm, Sweden.

Similar Private Companies By Industry

Company Name Region
Novartis Deutschland GmbH Europe
Actavis Deutschland GmbH & Co. KG Europe
hci-healthcare consult GmbH Europe
Syncare GmbH Europe
MIKA Pharma GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact vasopharm GmbH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at